HM Venture Partners

HM Venture Partners is a healthcare venture capital firm based in San Francisco, California, dedicated to investing in high-growth biotech and medtech companies across all stages. The firm actively manages three funds with approximately $600 million in assets under management, supporting a diverse portfolio of 60 companies globally. They provide crucial funding, deal sourcing, and strategic growth support to startups and entrepreneurs who are addressing significant unmet needs within large markets, often identifying high-potential ventures with roots in institutions like Mayo Clinic. Recent strategic team enhancements in 2024 include the addition of Venture Partners David Herbert and Harry Hoffman, both former Mayo Clinic executives. Furthermore, Managing Partner Robert Luo joined the board of portfolio company Melodi Health in 2024, highlighting active engagement, while OncoC4 stands out as another key portfolio success. HM Venture Partners was founded in 2019, quickly establishing itself in the healthcare investment landscape.